ICCT logo

iCoreConnect Inc. (ICCT) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

iCoreConnect Inc. (ICCT), Healthcare sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 55/100 puan alıyor.

Son analiz: 15 Mar 2026
55/100 AI Puanı

iCoreConnect Inc. (ICCT) Sağlık ve Boru Hattı Genel Bakışı

CEOAdam V. Chambers
Çalışanlar67
MerkezOcoee, US
Halka Arz Yılı2023
SektörHealthcare

iCoreConnect Inc. delivers HIPAA-compliant SaaS solutions for the healthcare industry, focusing on electronic prescriptions, insurance verification, and secure communication. With a negative profit margin and OTC market listing, the company faces challenges in a competitive landscape dominated by larger, more established players.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 15 Mar 2026

Yatırım Tezi

iCoreConnect operates in the growing healthcare information technology sector, offering a suite of HIPAA-compliant SaaS solutions. Key value drivers include the increasing adoption of electronic health records and the need for secure communication and data management in healthcare. However, the company's negative profit margin of -314.8% and OTC market listing present significant risks. Growth catalysts include expanding the customer base and introducing new product offerings. The company's ability to achieve profitability and gain market share in a competitive landscape will be critical to its long-term success.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • iCoreConnect Inc. operates in the Healthcare Information Services industry, providing cloud-based SaaS solutions.
  • The company's gross margin stands at 72.1%, indicating a strong ability to control the direct costs associated with its services.
  • iCoreConnect has a negative P/E ratio of -0.00, reflecting its current lack of profitability.
  • The company's profit margin is -314.8%, indicating significant losses relative to its revenue.
  • iCoreConnect operates with 67 employees, reflecting its relatively small size compared to larger competitors.

Rakipler & Benzerleri

Güçlü Yönler

  • HIPAA-compliant solutions.
  • Integrated suite of products.
  • Established presence in the healthcare IT market.
  • Specialized expertise in healthcare regulatory compliance.

Zayıflıklar

  • Negative profit margin.
  • Limited financial resources.
  • Small market capitalization.
  • OTC market listing.

Katalizörler

  • Upcoming: Potential new partnerships with EHR vendors to expand market reach.
  • Ongoing: Increasing adoption of electronic health records and telehealth solutions.
  • Ongoing: Growing demand for HIPAA-compliant data security solutions in healthcare.

Riskler

  • Potential: Intense competition from larger, more established players in the healthcare IT market.
  • Potential: Evolving healthcare regulations and compliance requirements.
  • Ongoing: Negative profit margin and limited financial resources.
  • Ongoing: OTC market listing and associated risks.

Büyüme Fırsatları

  • Expansion of iCoreVerify and iCoreVerify+ adoption: The market for automated insurance eligibility verification is growing as healthcare providers seek to reduce claim denials and improve revenue cycle management. iCoreConnect can capitalize on this trend by expanding the features of iCoreVerify and targeting larger healthcare organizations. The market size for healthcare revenue cycle management is projected to reach $107.9 billion by 2029.
  • Increased adoption of iCoreExchange: With growing concerns about data privacy and security, the demand for HIPAA-compliant email solutions is increasing. iCoreConnect can promote iCoreExchange as a secure alternative to traditional email for healthcare professionals, targeting practices that handle sensitive patient information. The global healthcare cybersecurity market is projected to reach $38.5 billion by 2027.
  • Strategic partnerships with EHR vendors: Collaborating with established EHR vendors to integrate iCoreConnect's solutions into their platforms can provide access to a wider customer base and accelerate adoption. This strategy can leverage the existing infrastructure and relationships of EHR vendors to expand iCoreConnect's market reach.
  • Development of new SaaS solutions: Expanding the product portfolio with new SaaS solutions that address emerging needs in the healthcare industry can drive revenue growth and attract new customers. Potential areas for expansion include telehealth platforms, remote patient monitoring solutions, and data analytics tools for healthcare providers.
  • Geographic expansion: While currently focused on the United States, iCoreConnect can explore opportunities to expand its operations into other countries with similar healthcare regulations and market needs. This expansion can be achieved through partnerships with local distributors or by establishing a direct presence in new markets.

Fırsatlar

  • Expansion of telehealth and remote patient monitoring.
  • Growing demand for data security and privacy solutions.
  • Strategic partnerships with EHR vendors.
  • Development of new SaaS solutions for healthcare providers.

Tehditler

  • Intense competition from larger, more established players.
  • Evolving healthcare regulations.
  • Cybersecurity threats and data breaches.
  • Economic downturn and reduced healthcare spending.

Rekabet Avantajları

  • HIPAA compliance: iCoreConnect's focus on HIPAA compliance provides a competitive advantage in the healthcare industry, where data security and privacy are critical.
  • Integrated suite of solutions: The company offers a range of integrated solutions that address various needs of healthcare providers, creating a stickier customer base.
  • Established customer base: iCoreConnect has an existing customer base that provides a foundation for future growth.
  • Specialized expertise: The company has specialized expertise in healthcare IT and regulatory compliance.

ICCT Hakkında

Founded in 1992 and rebranded as iCoreConnect Inc. in 2017, the company offers a suite of cloud-based software solutions designed to address the specific needs of healthcare professionals. Their flagship products include iCoreRx, an electronic prescription software, and iCoreVerify, an insurance eligibility verification tool. iCoreConnect also provides solutions for prescription drug monitoring (iCorePDMP), secure email communication (iCoreExchange), cloud data backup (iCoreCloud), claims processing (iCoreClaims), and patient payment processing (iCorePay). iCoreConnect operates primarily in the United States, targeting healthcare providers seeking to improve efficiency and compliance with HIPAA regulations. The company's solutions aim to streamline administrative tasks, enhance patient care coordination, and improve revenue cycle management for healthcare practices.

Ne Yaparlar

  • Provides HIPAA-compliant electronic prescription software (iCoreRx).
  • Offers a solution to check patient prescription drug history (iCorePDMP).
  • Provides automated insurance eligibility verification (iCoreVerify and iCoreVerify+).
  • Offers a tool to reveal the revenue potential of each patient (iCoreHuddle and iCoreHuddle+).
  • Provides a medical coding reference SaaS solution (iCoreCodeGenius).
  • Offers a secure email solution for healthcare professionals (iCoreExchange).
  • Provides cloud data backup services (iCoreCloud).
  • Offers claims processing and management solutions (iCoreClaims).

İş Modeli

  • SaaS subscriptions: iCoreConnect generates revenue through recurring subscription fees for its various software solutions.
  • Per-transaction fees: Some services, such as claims processing and payment processing, may involve per-transaction fees.
  • Managed IT services: iCoreIT provides managed IT services to healthcare practices, generating revenue through service contracts.
  • Partnerships: Revenue may be generated through strategic partnerships with other healthcare technology vendors.

Sektör Bağlamı

iCoreConnect operates within the healthcare information technology (IT) sector, which is experiencing significant growth driven by the increasing adoption of electronic health records (EHRs), the need for improved data security and compliance, and the growing demand for telehealth solutions. The market is competitive, with established players like ACNV (Accenture), CGHC (Cerner), EVLO (Evolus), HLTT (Hlth Corp), and INFIQ offering a range of healthcare IT solutions. iCoreConnect focuses on providing HIPAA-compliant SaaS solutions for specific healthcare needs, such as electronic prescriptions and insurance verification.

Kilit Müşteriler

  • Small to medium-sized healthcare practices.
  • Dental practices.
  • Physicians and specialists.
  • Hospitals and clinics.
AI Güveni: 71% Güncellendi: 15 Mar 2026

Finansallar

Grafik & Bilgi

iCoreConnect Inc. (ICCT) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

ICCT için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

ICCT için Wall Street fiyat hedefi analizi.

MoonshotScore

55/100

Bu puan ne anlama geliyor?

MoonshotScore, ICCT'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Adam V. Chambers

CEO

Adam V. Chambers serves as the Chief Executive Officer of iCoreConnect Inc. His professional background and educational details are not available in the provided context. Further research would be required to provide a comprehensive overview of his career history, previous roles, and credentials.

Sicil: Information regarding Adam V. Chambers' specific achievements, strategic decisions, and company milestones during his tenure as CEO of iCoreConnect Inc. is not available in the provided context. Further research would be required to assess his track record and contributions to the company's performance.

ICCT OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that iCoreConnect Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to companies listed on major exchanges like the NYSE or NASDAQ.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Given the OTC Other listing, iCoreConnect's stock likely experiences lower trading volume and wider bid-ask spreads compared to stocks on major exchanges. This can make it more difficult to buy or sell shares quickly and at a desired price. Investors should be prepared for potential price volatility and limited liquidity when trading ICCT shares.
OTC Risk Faktörleri:
  • Limited financial disclosure.
  • Low trading volume and liquidity.
  • Potential for price manipulation.
  • Higher risk of fraud or mismanagement.
  • Limited regulatory oversight.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's revenue and profitability trends.
  • Review the company's legal and regulatory compliance.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with investing in OTC stocks.
Meşruiyet Sinyalleri:
  • Company has been in business since 1992.
  • Offers a suite of HIPAA-compliant software solutions.
  • Focuses on a specific niche within the healthcare IT market.
  • Operates in a regulated industry (healthcare).

Yatırımcılar iCoreConnect Inc. (ICCT) Hakkında Ne Soruyor

ICCT için değerlendirilmesi gereken temel faktörler nelerdir?

iCoreConnect Inc. (ICCT) şu anda yapay zeka skoru 55/100, orta puanı gösteriyor. Temel güçlü yan: HIPAA-compliant solutions.. İzlenmesi gereken birincil risk: Potential: Intense competition from larger, more established players in the healthcare IT market.. Bu bir finansal tavsiye değildir.

ICCT MoonshotScore'u nedir?

ICCT şu anda MoonshotScore'da 55/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

ICCT verileri ne sıklıkla güncellenir?

ICCT fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler ICCT hakkında ne diyor?

ICCT için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

ICCT'a yatırım yapmanın riskleri nelerdir?

ICCT için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from larger, more established players in the healthcare IT market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

ICCT'ın P/E oranı nedir?

ICCT için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için ICCT'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

ICCT aşırı değerli mi, yoksa düşük değerli mi?

iCoreConnect Inc. (ICCT)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

ICCT'ın temettü verimi nedir?

iCoreConnect Inc. (ICCT) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is based on the most recent available information.
  • OTC market data may be limited or less reliable than data for major exchanges.
  • AI analysis is pending and will provide further insights into the company's prospects.
Veri Kaynakları

Popüler Hisseler